RalGEFs were recently shown to be critical for Ras-mediated transformed and tumorigenic growth of human cells. We now show that the oncogenic activity of these proteins is propagated by activation of one RalGEF substrate, RalA, but blunted by another closely related substrate, RalB, and that the oncogenic signaling requires binding of the RalBP1 and exocyst subunit effector proteins. Knockdown of RalA expression impeded, if not abolished, the ability of human cancer cells to form tumors. RalA was also commonly activated in a panel of cell lines from pancreatic cancers, a disease characterized by activation of Ras. Activation of RalA signaling thus appears to be a critical step in Ras-induced transformation and tumorigenesis of human cells.
Introduction
, although they do enhance transformation of NIH 3T3 cells expressing an activated version of Raf (Urano et al., 1996) or rat fibroblasts expressing the EGF receptor (Lu et al., The genes encoding the small GTPase Ras are mutated to 2000) , and dominant-negative Ral mutants suppressed Rasyield proteins that remain in the constitutively active GTP induced transformation of NIH 3T3 cells (White et al., 1996) . bound state in one-third of all human cancers, where they act Similarly, activated PI3K alone is not transforming, but enas oncoproteins and promote cancer-like growth of mammahances the transforming activity of Raf and, when inhibited, lian cells (Bos, 1989) . At least three primary Ras binding problocks Ras-mediated transformed cell growth of NIH 3T3 cells teins, or effectors, propagate oncogenic Ras signals: the Raf (Rodriguez-Viciana et al., 1997) . family of serine/threonine kinases that activate the ERK mito-Unlike the situation in mice, however, the RalGEF pathway gen-activated protein kinase (MAPK) pathway, known to proappears to play a more prominent role in transformation of humote cell proliferation; the phosphatidylinositol 3-kinases man cells. Specifically, normal human cells from a wide (PI3Ks), known to promote cell survival; and the Ral guanine spectrum of cell types are driven to a tumorigenic state upon nucleotide exchange factors (RalGEFs), activators of the RalA the expression of four proteins: SV40 T-Ag, which inhibits the and RalB Ras-related small GTPases (Shields et al., 2000) .
function of the tumor suppressors p53 and the Rb pocket pro-Activation of Raf or its downstream targets promotes soft teins; SV40 t-Ag, which indirectly activates c-Myc; the hTERT agar growth of rodent fibroblast, a transformed phenotype of catalytic subunit of telomerase, which is essential for the cancancer cells, and tumor formation (Shields et al., 2000) . On the cer phenotype of unlimited growth; and oncogenic (G12V) Ras other hand, neither RalGEFs nor PI3Ks are particularly trans- (Hahn et al., 1999; O'Hayer and Counter, 2005) . Using this apforming. Activated RalGEF or Ral proteins do not cause potent proach to transform identically matched primary human and transformed growth of rodent fibroblast or epithelial cells (Collette et al., 2004; McFall et al., 2001; Ulku and Der, 2003 ; Urano mice cells, it was found that murine cells were most potently transformed by Raf activation by replacing Ras with effector step to delineate the signaling pathways through which RalGEF mutants that preferentially activate only one of the major effectransforms human cells, we tested whether the GTP exchange tor pathways or with activated versions of the effectors themactivity of the RalGEF Rlf was required for transformation. A selves, whereas human cell transformation was mediated by retrovirus encoding no transgene as a control, or wild-type or activation of the RalGEF family of proteins. Moreover, the tucatalytically dead R328E mutant version of Rlf fused to the mor growth of the human cells was dependant upon the Ras plasma membrane targeting domain of K-Ras (termed CAAX), effector mutant that activates RalGEFs. Impeding RalGEF which is used to mimic the recruitment of Rlf to the plasma function via the expression of a dominant-negative version of membrane during Ras stimulation (de Ruiter et al., 2000;  Wolits substrate also diminished Ras-mediated transformation of thuis et al., 1996; Wolthuis et al., 1997) , were used to infect the same human cells (Hamad et al., 2002; Rangarajan et al., HEK-HT cells, primary human embryonic kidney cells that ec -2004) . Given the importance of RalGEF activation for transtopically express hTERT, T-Ag and t-Ag (Hahn et al., 1999) . formation of human cells, understanding how the RalGEF on-These cells provide a genetically defined human cell system to cogenic signal is transmitted could provide insight into the assay Ras oncogenesis (Hamad et al., 2002) . Expression of the mechanism of Ras-induced human tumorigenesis. desired proteins in the resultant polyclonal populations was Four human RalGEFs that share a common C-terminal Ras confirmed by immunoblot analysis ( Figure 1A ). We also verified association domain have been identified. GTP bound Ras relothat these two forms of Rlf-CAAX did not activate the Raf/MEK/ cates RalGEFs to the membrane fraction where they can pro-ERK and PI3K/Akt pathways, by measuring the level of phosmote the exchange of GDP to GTP on their only known subphorylated forms of ERK1/2 and Akt via immunoblot analysis strates, the membrane bound GTP binding proteins RalA and in serum-starved cells. As a control, we confirmed that Akt and RalB (Kishida et al., 1997; Matsubara et al., 1999) . The catalytic ERK1/2 are highly phosphorylated upon expression of Ras G12V activity of RalGEFs is also stimulated upon the association with ( Figure 1A ). The cells were next assayed for anchorage-indethe protein kinase PDK1 (Tian et al., 2002) , and RalGEFs have pendent growth when suspended in soft agar, one of the most been reported to have functions independent of the exchange stringent in vitro measures of the transformed phenotypes typiactivity (Bhattacharya et al., 2002; Tian et al., 2002) . In regard cal of cancer cells. Consistent with previous results (Hamad et to transformation, overexpression of activated Ral fosters anal., 2002) , expression of Rlf-CAAX alone was transforming, to chorage-independent growth and cell motility in a number of approximately half the level of anchorage-independent growth human cancer cell lines (Gildea et al., 2002; Ward et al., 2001;  observed in HEK-HT cells expressing the 37G effector domain Yamazaki et al., 2001) . Additionally, disruption of Ral activation mutant of oncogenic Ras (not shown) that is partially defective with either small interfering RNAs (siRNA) or inhibition of Ral at activating PI3K and MAPK, but retains the ability to activate effector activation impairs the growth of several human cancer RalGEFs (Rodriguez-Viciana et al., 1996; Shields et al., 2000 ; cell lines in short-term suspension culture (Chien and White, 2003) . White et al., 1995; White et al., 1996) . However, the catalytically To date, three classes of Ral effectors have been identified:
dead Rlf R328E -CAAX failed to transform human cells (Figure the Cdc42/Rac GTPase-activating protein RalBP/RLIP76; the 1B), indicating that Ral GTPase activation is likely responsible Sec5 and Exo84 subunits of the exocyst complex; and the acfor RalGEF-mediated transformation. tin binding protein filamin (Cantor et al., 1995; Jullien-Flores et al., 1995; Moskalenko et al., 2003;  Activation of RalA, but not of RalB, Ohta et al., 1999; Park and Weinberg, 1995) . Both RalA and RalB also bind constitutively to phospholipase D1 (PLD1) (Luo transforms human cells et al., 1997) and stimulate the activation of c-src, c-jun, AFX,
We next determined which of the RalA or RalB proteins was STAT, and NF-κB, as well as cyclin D, through as yet unidenresponsible for RalGEF-mediated transformation by assaying tified effectors (de Ruiter et al., 2000; Goi et al., 2000; whether activated forms of RalA or RalB alone could transform al., 2000; Kops et al., 1999) . To add to the complexity, despite human cells. We used RalA and RalB mutated to G23V or Q72L greater than 85% identity, RalA and RalB appear to perform to disrupt their intrinsic and GTPase activating protein (GAP)different functions. For instance, RalA has a much higher affinstimulated GTPase activity, which leaves the proteins in a conity for the exocyst complex than does RalB, and only RalA stitutively active GTP bound state and insensitive to Ral-GAP stimulates exocyst function to enhance the rate of delivery of activity (Emkey et al., 1991; Frech et al., 1990) , or RalA and membrane proteins to the basolateral membrane of epithelial RalB mutated to F39L, which is analogous to the same mutacells (Shipitsin and Feig, 2004) . It has also been reported that tion in Ras that promotes fast cycling between GDP and GTP suppression of RalA by siRNA inhibits cancer cell growth in bound states (Reinstein et al., 1991) , as such a mutation mimsuspension culture, whereas similar suppression of RalB in ics interaction with GEFs and is oncogenic in both Ras and these cells leads to apoptosis (Chien and White, 2003) . As Ral-Rho small GTPases (Lin et al., 1997; Reinstein et al., 1991) . GEFs are important for Ras-induced tumorigenesis of human These three mutants and their wild-type counterparts were stacells and accumulating data suggest that Ral proteins may mebly expressed in HEK-HT cells, as assessed by immunoblot diate functions of RalGEFs, we explored whether the RalGEF analysis. As expected, these proteins did not activate the PI3K substrates RalA and RalB play a role in transformed and tumoror MAPK pathways ( Figure 1A ). When the resulting cells were igenic growth of human cells.
assayed for growth in soft agar, no version of RalB supported anchorage-independent growth, consistent with our previous Results and discussion results that RalB was not transforming (Hamad et al., 2002) . Conversely, all RalA proteins transformed HEK-HT cells to The GTP exchange activity of a RalGEF is necessary some degree, although the most transforming versions were for human cell transformation clearly those with the activating (G23V or Q72L) mutations ( Immunoblot analysis of HA-epitope-tagged Rlf-CAAX, Ras, RalA, and RalB in HEK-HT cells (A) or BJ-HT (C) cells stably infected with retroviruses encoding the described transgenes. MAPK and PI3K activity were measured in the described cells by detecting phosphorylation of ERK1/2 (P-ERK1/2) and Akt (P-Akt), respectively, with phosphospecific antibodies. Actin, total ERK1/2, and total Akt served as loading controls. Anchorage-independent growth of HEK-HT (B) and BJ-HT cells (D) expressing the described transgenes, as calculated from the average number of colonies ±SD from six plates (two independent experiments conducted in triplicate) and expressed as the percentage of colonies in Rlf-CAAX-transformed cells. *, p = 0.00002 between vector and RalA; **, p = 0.002 between RalA and RalA F39L (two-tailed Student's t test)
expressing activated RalA were smaller than those observed constitutively activated RalA (RalA Q72L ) and, to a very small degree, wild-type RalA, but not any version of RalB, was also in the positive control, Rlf-CAAX-expressing cells. As such, all cultures were assayed for anchorage-independent growth 1 transforming in fibroblasts ( Figure 1D ). Given the fact that activated RalA alone caused growth transformation of two very week later than typically needed to detect soft agar growth. Since Rlf-CAAX was more transforming than activated RalA, it different human cell types, we argue that activation of this protein may be broadly sufficient to promote Ras-mediated trans-is possible that either RalGEF signaling involves more than the mere activation of RalA, or that expression of constitutively ac-formation of human cells. tivated RalA mutants fails to recapitulate either the magnitude or proper localization of RalA activated by RalGEFs that is Inhibition of RalA binding to RalBP1 and Sec5 needed to promote full transformation. Nevertheless, as actisuppresses transformation vated forms of RalA, and no variant of RalB, transformed hu-RalA is known to bind to and promote the activation of a numman cells, the signaling events leading to anchorage-indepenber of proteins, including phospholipase D1 (PLD1), the Sec5 dent growth in the RalGEF pathway involve activation of RalA.
and Exo84 subunits of the exocyst complex, and the Cdc42/ We next confirmed the transforming activity of RalA in a Rac GTPase-activating protein RalBP1/RLIP76 (Cantor et al., completely different cell type. Normal human fibroblasts ectop-1995; Jullien-Flores et al., 1995; ; Ohta ically expressing hTERT, T-Ag, and t-Ag (BJ-HT cells; Hahn et et al., 1999; Park and Weinberg, 1995) . PLD1 binding is medial., 1999) were stably infected with retroviruses encoding wildated through the N terminus of RalA, whereas binding to the type or the Q72L-activated versions of RalA or RalB, or Rlfother proteins is mediated through the core effector loop region CAAX (as a positive control), or the catalytically dead version within the conserved switch 1 domain. Ral also contains the of Rlf-CAAX or no transgene (as negative controls). Resultant conserved switch 2 region that, together with the switch 1 repolyclonal populations were confirmed to express the desired gion, changes the conformation during GDP/GTP cycling, as well as a C-terminal hypervariable domain that appears to de-protein by immunoblot analysis ( Figure 1C ) and assayed for anchorage-independent growth. Although Ras-mediated trans-termine the proper subcellular localization of the protein with a highly conserved CAAX tetrapeptide motif, which signals for formation of human fibroblasts can be weaker than that observed in HEK cells (Hahn et al., 1999; Hamad et al., 2002) , the posttranslational modification by geranylgeranyl isoprenoid A: Schematic representation of RalA Q72L effector mutants. PLD, PLD binding domain; SW1and SW2, switch domains 1 and 2; Var, C-terminal hypervariable domain. B: Detection of RalA protein by immunoblot analysis in HEK-HT cells stably infected with a retroviral vector encoding no transgene (vector) or one of the described RalA Q72L mutants. Actin serves as a loading control. C: Anchorage-independent growth of polyclonal HEK-HT cells stably expressing the indicated RalA Q72L effector mutants, as calculated from the average number of colonies ± SD from six plates (two independent experiments conducted in triplicate) and expressed as the percentage of colonies detected in RalA Q72Ltransformed cells.
lipid essential for membrane association and biological activity binding to these two proteins may be important for full RalAmediated transformation. (Figure 2A ). To address which effectors of RalA are required for transformation, we examined the transforming ability of a panel of activated RalA mutants selectively defective in interacting RalB inhibits RalGEF-mediated transformation with the aforementioned binding proteins. Specifically, the Activated RalB alone was not transforming, despite being ⌬N11RalA Q72L mutant is truncated in the first 11 amino acid, >85% identical to RalA and capable of binding RalA effectors. reducing PLD1 binding (Jiang et al., 1995) ; the RalA D49E,Q72L
To further explore the relationship between RalA and RalB in mutant is defective in binding to Sec5 and Exo84 (Moskalenko transformation, we tested whether ectopic expression of wildet al., 2002; Moskalenko et al., 2003) ; and the RalA D49N, Q72L type RalB could inhibit RalGEF-induced transformation. Wildmutant has diminished affinity for RalBP1 (Cantor et al., 1995) .
type RalA, RalB, or a vector control was stably expressed in These different RalA Q72L mutants were stably expressed, as HEK-HT cells harboring either Rlf-CAAX, to activate the Ral proteins, or, as a negative control, the catalytically dead assessed by immunoblot analysis, in HEK-HT cells ( Figure 2B ) and assayed for growth in soft agar. The ⌬N11RalA Q72L re-Rlf R328E -CAAX protein ( Figure 3A ). Wild-type RalA, which was extremely weak in transforming in the presence of Rlf R328E -tained the transforming potency of RalA Q72L , indicating that binding between RalA and PLD1 is not essential for RalA-medi-CAAX, slightly enhanced the transforming ability of Rlf-CAAX ( Figure 3B ), whereas a constitutively active RalA was even ated cellular transformation ( Figure 2C ). In agreement, we find that activated RalA is the most transforming ( Figures 1B, 1D , more potent ( Figures 3C and 3D) . Conversely, wild-type RalB reduced the transforming ability of Rlf-CAAX by 40%-50%. and 2C), even though PLD1 can also bind to RalA in the GDP bound inactive state (Jiang et al., 1995) . Mutations disrupting On the basis of these observations, we reasoned that ectopic RalB may compete with endogenous RalA for Rlf-CAAX, RalA binding to RalBP1 or Sec5, however, reduced anchorageindependent growth by up to~70%, supporting the idea that as well as for RalA effectors needed for transformation. In sup- Our previous study using the MDCK cell line showed not only that active RalA binds more effectively to the exocyst than suggesting that the mode inhibition involves competition for Rlf-CAAX. However, upon making RalB independent of RalGEF does RalB, but also that active RalA, but not RalB, localizes to perinuclear recycling endosomes (Shipitsin and Feig, 2004) . In activation via the Q72L mutation, RalB Q72L could clearly inhibit Rlf-CAAX-mediated transformation, and this inhibition was re-HEK-HT cells, endogenous RalA and RalB were mostly punctuate throughout the cytoplasm and generally did not colocalize, duced 40% to 50% upon disrupting binding to the exocyst complex (RalB Q72L,D49E ); in contrast, disruption of RalBP1 as assessed by immunofluorescence analysis. Upon stimulation of endogenous Ral proteins by ectopic Ras G12V , there was binding (RalB Q72L,D49N ) did not affect the activity of RalB Q72L in inhibiting Rlf-CAAX-mediated transformation, in agreement a relatively greater increase in the concentrations of RalA compared to RalB in vesicular-like bodies in the perinuclear region with RalB competing for RalA effectors (Figures 3E and 3F) . It is worth noting that the inhibition depended upon overexpressing ( Figure 4A ). We thus postulated that these differences in the subcellular localization of RalA and RalB may contribute to RalB, as ectopic RalB impeded transformation mediated by endogenous RalA, but not in cells overexpressing RalA Q72L their ability to function in a pro-or antioncogenic fashion. The C terminus of RalA possesses a hypervariable region ( Figures 3C and 3D) . Thus, whereas RalA mediates RalGEFinduced transformation, this transformation can be blunted by terminating in a CAAX motif, both of which are known to be essential for proper localization of active RalA and for its func-overexpression of RalB, possibly by competition for RalGEF activation and RalA effectors.
tion as a stimulator of secretion (Shipitsin and Feig, 2004) . To determine whether these domains are essential for RalA-medi-efficiency of RalA Q72L (Figure 4D ). Thus, targeting RalB, a protein that normally inhibits transformation, to sites of activated ated transformation, we removed the C-terminal hypervariable region (RalA Q72L,⌬Var ) or the CAAX motif (RalA Q72L,⌬CAAX ; Figure RalA endowed RalB with transforming functions. The opposite was also true-namely, targeting RalA to RalB 2A) from RalA Q72L and expressed these two mutants in HEK-HT cells ( Figure 2B ). When assayed in soft agar, we found that subcellular domains impeded the transforming activity of RalA. When the C-terminal hypervariable region of RalA was disrupting either of these C-terminal regions reduced the transforming capability of RalA Q72L almost to the level of negative switched to that of RalB ( Figure 4B ) and expressed in HEK-HT cells ( Figure 4C ), the resultant RalA Q72L /B chimera failed to control vector cells ( Figure 2C ). Thus, proper subcellular localization is required for Ral-mediated transformation.
colocalize with RalA-associated vesicles. Instead, there was an overall increase of colocalization of RalA Q72L /B with endoge-Because activated RalA and RalB reside in different sets of membrane compartments and as this localization is mediated nous RalB throughout the cytoplasm ( Figure 4A , fourth row). Consistent with this mislocalization, the RalA Q72L /B mutant by C-terminal regions of the proteins that are required for RalA transformation, we surmised that RalB could be converted, at showed a 40% to 50% decrease in its ability to support anchorage-independent growth compared to RalA Q72L . least partially, to a transforming protein by targeting it to the subcellular domains occupied by activated RalA. We therefore
We surmise that the distinct subcellular localization of activated RalA and RalB may play a role in the effect of these expressed in human HEK-HT cells an activated RalB (RalB Q72L ) in which the C-terminal domain was replaced with the corre-proteins on cell transformation. However, the transforming activity of RalA was not completely abolished by mislocalizing, sponding region from RalA (Figures 4B and 4C ). As previously described in MDCK cells (Shipitsin and Feig, 2004) , the nor was RalB as efficient at transformation as RalA when targeted to RalA-associated vesicles ( Figure 4D ). These find-RalB Q72L /A protein associated with perinuclear vesicle-like bodies, which is not normally seen with wild-type RalB, even ings are consistent with our previous observation that RalA and RalB also differ in their ability to bind to at least one effector, in Ras G12V overexpressing cells ( Figure 4A, second row) . Colocalization of RalB Q72L /A with endogenous RalA in these vesi-the exocyst complex, with RalA binding more strongly to the exocyst than RalB (Shipitsin and Feig, 2004) . Thus, in addition cles was also substantially increased ( Figure 4A, third row) . This altered localization endowed RalB with the ability to trans-to the distinct subcellular localization patterns of RalA and RalB, differential affinities for effectors may also contribute to form human cells. HEK-HT cells expressing RalB Q72L /A were able to grow in soft agar, albeit at~50% of the transformation the disparate transforming potential of these two proteins.
Figure 5. RalA is critical for Ras-induced transformation
A: Detection of RalA, RalB, and Ras by immunoblot analysis in HEK-HT cells transformed by Ras G12V , Ras G12V,E37G , Rlf-CAAX, or RalA Q72L and subsequently stably infected with retroviral vectors encoding siRNA (+) targeting RalA, RalB, or both, or as negative control, a scramble sequence (S). Actin level serves as a loading control. B: Anchorage-independent growth of polyclonal HEK-HT cells transformed by the described transgenes stably expressing the indicated siRNA against RalA and/or RalB, or a scramble sequence (scram) as negative control, as calculated from the average number of colonies ± SD from six plates (two independent experiments conducted in triplicate), expressed as the percentage of colonies observed in scramble control-treated cells.
Loss of RalA inhibits Ras-induced transformation this article online). Perhaps related, transient knockdown of
RalA was shown to decrease the proliferation of human cancer Ectopically expressed RalA is transforming, whereas RalB impedes transformation. Given the inherent limitations of inter-cells when suspended in media (Chien and White, 2003) . Conversely, knockdown of RalB in HEK-HT cells transformed preting phenotypes resulting from overexpressed proteins, we confirmed these results by loss-of-function analysis. Endoge-via activation of the RalGEF pathway led to an increase in growth in soft agar. This effect was even greater in cells trans-nous RalA, RalB, or both, were stably knocked down by siRNAs directed against the mRNAs encoding these proteins in HEK-formed by oncogenic RalA, indicating that the antioncogenic activity of RalB is mediated, at least in part, through antagoniz-HT cells expressing Ras G12V , Ras G12V,E37G , or Rlf-CAAX ( Figure  5A ). For negative controls, an empty vector or one encoding ing the transforming activity of RalA ( Figure 5B ). However, in the more oncogenic situation in Ras G12V -transformed cells, scrambled versions of the siRNA sequences were introduced into the transformed HEK-HT cells. All 12 cell lines were then knockdown of RalB had no measurable effect. Although transient knockdown of RalB was previously reported to greatly assayed for growth in soft agar. Consistent with RalA activation being critical for Ras-mediated transformation, knockdown of reduce the proliferative potential of cancer cells by stimulating apoptosis (Chien and White, 2003) , this does not appear to be RalA in HEK-HT cells transformed via activation of the RalGEF pathway, by either Ras G12V,E37G or Rlf-CAAX, nearly abolished the case with stable expression of the described RalB siRNA in HEK-HT cells or in four human pancreatic cancer cell lines transformation and reduced oncogenic Ras-transformed cell growth by more than half ( Figure 5B ). This was not an off-target ( Figures 5B and 7B) . This discrepancy is due to a difference in cell type, the degree of inhibition of RalB expression, or the effect of RNAi, as identical results were obtained with independent siRNA generated against different regions of RalA and method by which RNAi is performed. In fact, the increase in transformation upon stable knockdown of RalB that we de-RalB (see Figure S1 in the Supplemental Data available with tected is in complete agreement with the observation that thus, any effect observed must be related to tumorigenesis ( Figure 6B) . Lastly, the loss of tumorigenic potential by RalA overexpression of RalB inhibited transformation by Rlf-CAAX knockdown was completely reversed by expression of a RalA (Figures 3B and 3D) . Lastly, we noted that simultaneous knockprotein engineered to be resistant to RalA siRNA (Figures 6A down of both RalA and RalB was somewhat more potent than and 6D). Thus, activation of RalA is critical, if not essential, for was knockdown of RalA alone in inhibiting the transforming Ras-mediated tumorigenic growth of human HEK-HT cells. ability of Ras G12V,E37G or Rlf-CAAX, perhaps reflecting a general requirement for some level of Ral signaling. In summary, the Suppression of RalA inhibits the tumorigenic growth described loss-of-function studies support the conclusions of human cancer cell lines drawn from analysis of cells overexpressing RalA or RalB: i.e.,
We next addressed whether RalA expression was required for activated RalA and RalB primarily oppose one another in transtumorigenic growth of human cancer cell lines harboring an formation, with RalA mediating, and RalB inhibiting RalGEF onactivated Ras mutation. To this end, a retrovirus expressing cogenic signaling. either the RalA siRNA or the scrambled sequence was stably introduced into the human cancer cell line HT1080, a fibrosar-RalA is critical for Ras-induced tumorigenesis coma cell line, J82, a bladder cell carcinoma cell line, and Given the importance of RalA in Ras-mediated transformation, SW620, a colon adenocarcinoma cell line (Brown et al., 1984 ; we next addressed the role of each Ral protein in the most Di Paolo et al., 2001; Fujita et al., 1988) , and the resultant cells stringent assay: tumorigenesis. RalA and/or RalB were stably were shown to have either reduced or unaltered levels of RalA, knocked down by siRNA in the highly tumorigenic Ras G12Vrespectively ( Figure 7A ). Scramble control cells in all three transformed HEK-HT cells ( Figures 5A and 6C) , and the resulcases readily formed tumors when injected into immunocomtant cells were injected into immunocompromised mice. As a promised mice, whereas suppression of RalA increased the latcontrol, we utilized the same cells engineered to express the ency period of tumor initiation and decreased the tumor growth corresponding scrambled counterparts. Consistent with the kinetics. These decreases were slight in the case of SW620 soft agar results, reducing RalB expression had only marginal cells, whereas knockdown of RalA in the J82 cell line abolished effects on Ras G12V -mediated tumor growth, perhaps because the tumorigenic potential of these cells as no tumors were deloss of RalB can do little to enhance the already extremely tutected even after 100 days, fully 5-fold longer than the average morigenic functions of Ras ( Figure 6A ). Also consistent with the time taken to initiate tumor growth in the presence of RalA (Figin vitro experiments, loss of RalA in Ras G12V -transformed HEKure 7B). Thus, RalA is important, and possibly essential in HT caused a 2-fold increase in the latency period and a reducsome cases, for the tumorigenic growth of human cancer cell tion in the growth kinetics of the outgrowing tumors ( Figure  lines with an activated Ras pathway. 6A). In cases in which tumors eventually did arise, RalA expression was restored, possibly through in vivo selection of cells RalA is in the GTP bound active state in pancreatic from the initial polyclonal population that had low levels of cancer cell lines siRNA ( Figure 6C ). Knockdown of RalA had no measurable ef-To further explore the role of RalA in human cancer, we asked to what extent RalA exists in the GTP bound, active state in fect on the ability of the cells to survive and proliferate in vitro; cells of cancers characterized by oncogenic Ras mutations.
in at least 11 of the lines, high levels of ERK phosphorylation were only seen in one-third of these lines. Similarly, AKT was K-Ras is mutated in almost 90% of tumors from patients diagnosed with pancreatic cancer (Bos, 1989) . Hence, we mea-only weakly activated in the panel of cancer cell lines, with high levels of phosphorylated AKT detected in just three lines ( Fig-sured the levels of GTP bound and total RalA in a panel of 14 pancreatic human cancer cell lines, most of which were known ure 8A). Intriguingly, we also found that the total K-Ras protein and K-Ras-GTP levels varied enormously among the cancer to have an activating mutation in one allele of the K-Ras gene (Berrozpe et al., 1994; Calhoun et al., 2003; Iwamura and Hol- cell lines, again despite the fact that RalA-GTP was usually readily detected, suggesting a need to conserve RalA activa-lingsworth, 1998; Kalthoff et al., 1993; Moore et al., 2001; Ryu et al., 2002) . Immunoblot analysis revealed that total RalA pro-tion, even in the event of diminished Ras protein levels ( Figure  8A ). In support of this model, independent of the amount of tein was present, at variable levels, in all of these tumor cell lines. RalA-GTP protein was isolated via an interaction with a RalA, RalB, PI3K, or MAPK activation, we showed that knockdown of RalA in four of these human pancreatic cancer cell recombinant polypeptide encoding the Ral binding domain of the Ral effector protein RalBP1, followed by immunoblot analy-lines almost uniformly reduced their ability to grow in soft agar. Conversely, knockdown of RalB in the same cell lines had little sis to detect RalA Wolthuis et al., 1998b) . While undetectable or low levels of RalA-GTP were or no effect on the ability of the cells to grow on plastic or in suspension ( Figure 8C and data not shown). The finding of seen in a subset of the cell lines ( Figure 8A , CFPac-1, Colo 357, and Colo 587), similar to the levels seen in a variety of RalA being commonly activated in pancreatic cancer cell lines is consistent with a critical role for this effector in tumori-untransformed epithelial cells (McFall et al., 2001; Ulku and Der, 2003) and in normal human pancreatic tissue ( Figure 8B) , genesis. total RalA-GTP levels were elevated in the remaining majority of cell lines ( Figure 8A ). This level of RalA-GTP elevation is
RalA and RalB function in Ras oncogenesis
We show that RalA is a principal effector of RalGEFs involved comparable to that in a variety of Ras-transformed cells (McFall et al., 2001; Ulku and Der, 2003) and was reduced upon in Ras-mediated transformation and tumorigenesis, as a constitutively active version of RalA promoted anchorage-indepen-the knockdown of oncogenic K-Ras in Capan-1 cells ( Figure  8B) , arguing that this level of RalA-GTP represents an abnormal dent growth whereas inhibition of RalA expression lowered, and, in some cases actually abolished, Ras-mediated trans-activation of RalA. In contrast, while RalB protein was detected in these cancer cell lines, RalB-GTP levels were only highly formation and tumorigenesis. While this pathway was not strongly transforming on its own-indicating a collaborative elevated in three of the lines. In summary, the transforming RalA protein, but not the nontransforming RalB protein, is pref-role with other Ras effector pathways-decreasing RalA expression clearly reduced tumorigenic growth. As a decrease of erentially in its activated state in human pancreatic cancer cells.
RalA expression had no obvious effect on the cells until they were placed in an oncogenic environment, aberrant RalA acti-Most surprisingly, RalA was more commonly activated compared to the other major Ras effector pathways in these cancer vation presumably performs a task required uniquely in the process of tumorigenesis. cell lines. While ERK1/2 were phosphorylated to some degree Figure 8 . RalA is commonly activated in pancreatic cancer cells to promote transformed cell growth A: Detection of activated GTP bound K-Ras, RalA, and RalB via association with effector protein domains specific for activated versions of these proteins, followed by immunoblot analysis with antibodies specific for K-Ras, RalA, or RalB in a panel of 14 pancreatic cancer cell lines. Detection of MAPK and PI3K activation in the same cell lines, by immunoblot analysis with phosphospecific antibodies for phosphorylated forms of ERK1/2 (P-ERK1/2) and Akt (P-Akt), respectively. Total K-Ras, RalA, RalB, ERK1/2 and Akt, or actin, serve as loading controls. B: Detection of activated GTP bound RalA via association with an effector protein domain specific for the activated version of this protein followed by immunoblot analysis with an antibody specific for RalA in normal human pancreatic tissues from three separate donors (1, 2, and 3) or Capan-1 cells stably infected with a control retrovirus (v) or one encoding siRNA specific to the 12V mutant allele of K-Ras that knocks down K-Ras expression, as determined by immunoblot analysis. Total RalA or actin serve as loading controls. C: Detection of RalA or RalB by immunoblot analysis in the described pancreatic cancer cell lines stably infected with retroviral vector alone (vector) or encoding siRNA targeting RalA or RalB. Actin serves as a loading control. Bottom: anchorage-independent growth of the indicated cell lines, as calculated from the average number of colonies from three plates and expressed as the percentage of colonies observed in vector control cells, except for Capan-2 cultures, which were only counted in one plate because replica plates showed no visible difference in colony formation among the three cell lines.
Ral proteins have been implicated in the regulation of a vari-for filopodia formation (Ohta et al., 1999; Takaya et al., 2004) , which may be needed for transformation-associated remodel-ety of cellular functions that could conceivably account for their oncogenic activity, including enhancement of gene transcrip-ing of cell structure. While RalA behaved in an oncogenic fashion, RalB func-tion and regulation of vesicle trafficking. We favor the latter possibility because enhancement of transcription is mediated tioned in exactly the opposite manner. RalB overexpression inhibited, while RalB siRNA treatment enhanced, Rlf-CAAX by both RalA and RalB (Goi et al., 2000; Henry et al., 2000) , while in our assays only RalA promoted transformation. More-transformation. We suggest that the modus operandi of RalB antioncogenic behavior may be to both compete for binding over, RalA, but not RalB, promotes basolateral membrane delivery in MDCK cells (Shipitsin and Feig, 2004) , as well as trans-to RalGEFs, resulting in a decrease in RalA activation, and to sequester Ral effectors to subcellular sites nonproductive for formed and tumorigenic growth of human cells. Both of these activities require proper localization to perinuclear vesicles and oncogenic signaling, akin to the roles proposed for RalB in inhibiting Ral-mediated basolateral membrane delivery (Shipitsin depend upon the C-terminal variable domain of RalA. Replacing this domain with that of RalB decreased the transforming and Feig, 2004). However, RalB was rather ineffectual at blocking Ras-mediated transformation. This could be because Ras and membrane delivery activities of RalA, while replacing the C terminus of RalB with that of RalA endowed RalB with partial activates pathways that circumvent RalB inhibitory signals, because RalA competes more successfully for effector binding, transforming and membrane delivery activities. How the effects of RalA on vesicle sorting may be linked to its ability to trans-or because RalA is preferentially activated in cancer cells, as supported by the observation that RalA, and not RalB, was form human cells is not yet clear. Perhaps Ral-exocyst interactions are involved in secretion, which could be a factor in au-commonly activated in our panel of 14 human pancreatic cancer cell lines. Similarly opposing functions in growth regulation tocrine stimulation of cells, similar to the proposed role of Cdc42 in the transformation of cells (Wu et al., 2003) . Alterna-have been described for the highly related RhoA and RhoB small GTPases (Adnane et al., 2002; Jiang et al., 2004) . Despite tively, Ral-exocyst interactions are also thought to be critical Immunofluorescence strong sequence identity and similar effector interaction, RhoA
The described cells were plated on glass microslides the previous day, activation has been associated with growth promotion, whereas fixed, permeabilized, and incubated with anti-Flag, anti-Myc (9E10), anti-RhoB exhibits the characteristics of a tumor suppressor (Jiang RalA, and anti-RalB primary antibodies, followed by the appropriate HRPet al., 2004) . The functional differences between RhoA and conjugated secondary antibodies (Jackson Immunoresearch Laboratory) as RhoB have been ascribed to differences in subcellular localizapreviously described (Etheridge et al., 2002) . tion (Wang et al., 2003) .
Soft agar
In summary, we show that RalA plays a central role in Ras-50,000 cells per 3cm plate were suspended in soft agar as described (Cimediated tumorigenesis, as loss of RalA function impedes, if fone and Fidler, 1980; Hamad et al., 2002) and colonies >30 cells scored not abolishes, the growth of human tumor cells and is widely after 4 weeks. Assays were performed in triplicate and at least twice indeactivated in pancreatic cancer cell lines. Inhibiting RalA funcpendently. tion may therefore be an effective anti-Ras strategy for can-Tumorigenesis cer treatment.
According to a protocol approved by the Duke University Institutional Animal Care and Use Committee, 1 × 10 7 cells mixed with Matrigel were in-Experimental procedures jected subcutaneously into the flanks of 4 SCID/beige mice per cell line, after which tumor volumes were determined at regular intervals as de-Cell lines scribed previously (Hamad et al., 2002) . Tumors were harvested, minced, Human embryonic kidney cells (HEK-HT) and BJ fibroblasts (BJ-HT) stably and trypsinized for 2 hr at 37°C and then passed through 18G needles, expressing the early region of SV40 encoding T-Ag and t-Ag and hTERT washed, and plated in DMEM/10% FBS plus puromycin at least 4 days were previously described (Hahn et al., 1999; Hamad et al., 2002) . HT1080 before immunoblot analysis was performed. and J82 cell lines were obtained from ATCC; the SW620 cell line or normal human pancreas tissues from three different donors were kind gifts of X.-F. Wang or A.D. Proia and D. Tyler, respectively (Duke University Medical Cen-Supplemental Data ter, Durham, NC). HT1080 and SW620 cell lines are known to contain a mutant Ras allele (Brown et al., 1984; Di Paolo et al., 2001; Fujita et al., Supplemental Data include one figure and can be found with this article 1988). The J82 cell line was confirmed by RT-PCR and direct sequencing online at http://www.cancercell.org/cgi/content/full/7/6/533/DC1/. to contain a G12V mutation in H-Ras. The pancreatic cell lines were ob-
